Hi Jock, I have never prescribed to the theory that we need to complete phase 2, though I agree many on here do and have said that to you. I'm not worried about phase 2 as much, because I think Neurizon will get an offer of some sort E.g. Partnership or possibly take over before it ends. We now know the patents were not as strong as we believed, but that has now been fixed. Big pharma were asked what they needed to see and the pre clinical work was the result. [I'm sure there were other reasons as well] I suspect they wanted to better understand the MOA. That is now happening. So we are finding out there was stuff we didn't know that we didn't know.
I may be wrong, but with the evidence pilling up someone will step up. Some say it is worth $10+ a share and I believe that will be the case if Neurizon is still around when NUZ001 is being prescribed and on sale. But I suspect it will be sold for a price lower and sooner than that. Ether way I will be happy with an early sale.
Then again I could be wrong
Cheers
NUZ Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)